| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.34e-04 | 65 | 80 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.33e-04 | 30 | 80 | 3 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.57e-04 | 31 | 80 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 2.92e-04 | 145 | 80 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.78e-04 | 85 | 80 | 4 | GO:0019199 | |
| Domain | Tyr_kinase_rcpt_ROR | 1.68e-05 | 2 | 77 | 2 | IPR016247 | |
| Domain | TyrKc | 3.13e-05 | 88 | 77 | 5 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.13e-05 | 88 | 77 | 5 | IPR020635 | |
| Domain | Kringle | 4.39e-05 | 17 | 77 | 3 | IPR000001 | |
| Domain | Kringle_CS | 4.39e-05 | 17 | 77 | 3 | IPR018056 | |
| Domain | KRINGLE_2 | 4.39e-05 | 17 | 77 | 3 | PS50070 | |
| Domain | Kringle | 4.39e-05 | 17 | 77 | 3 | PF00051 | |
| Domain | KRINGLE_1 | 4.39e-05 | 17 | 77 | 3 | PS00021 | |
| Domain | KR | 4.39e-05 | 17 | 77 | 3 | SM00130 | |
| Domain | PROTEIN_KINASE_TYR | 5.01e-05 | 97 | 77 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 5.01e-05 | 97 | 77 | 5 | IPR008266 | |
| Domain | FAM47 | 1.00e-04 | 4 | 77 | 2 | PF14642 | |
| Domain | FAM47 | 1.00e-04 | 4 | 77 | 2 | IPR032743 | |
| Domain | Pkinase_Tyr | 1.93e-04 | 129 | 77 | 5 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.64e-04 | 138 | 77 | 5 | IPR001245 | |
| Domain | Kringle-like | 3.07e-04 | 32 | 77 | 3 | IPR013806 | |
| Domain | Znf_PHD | 5.44e-04 | 91 | 77 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.40e-04 | 95 | 77 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 6.66e-04 | 96 | 77 | 4 | PS01359 | |
| Domain | Tyr_kinase_rcpt_2_CS | 9.01e-04 | 11 | 77 | 2 | IPR002011 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.08e-03 | 12 | 77 | 2 | PS00239 | |
| Domain | Kinase-like_dom | 1.73e-03 | 542 | 77 | 8 | IPR011009 | |
| Domain | - | 2.67e-03 | 67 | 77 | 3 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 2.67e-03 | 67 | 77 | 3 | IPR029034 | |
| Domain | PROTEIN_KINASE_ATP | 2.83e-03 | 459 | 77 | 7 | PS00107 | |
| Domain | PHD | 3.68e-03 | 75 | 77 | 3 | PF00628 | |
| Domain | Prot_kinase_dom | 4.01e-03 | 489 | 77 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 4.19e-03 | 493 | 77 | 7 | PS50011 | |
| Domain | Znf_PHD-finger | 4.26e-03 | 79 | 77 | 3 | IPR019787 | |
| Domain | Frizzled_dom | 4.37e-03 | 24 | 77 | 2 | IPR020067 | |
| Domain | FZ | 4.37e-03 | 24 | 77 | 2 | PS50038 | |
| Domain | Fz | 4.37e-03 | 24 | 77 | 2 | PF01392 | |
| Domain | PHD | 5.93e-03 | 89 | 77 | 3 | SM00249 | |
| Pubmed | 1.52e-06 | 83 | 81 | 5 | 11114734 | ||
| Pubmed | Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. | 5.36e-06 | 2 | 81 | 2 | 11429290 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 34763666 | ||
| Pubmed | IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas. | 5.36e-06 | 2 | 81 | 2 | 26173023 | |
| Pubmed | A novel family of cell surface receptors with tyrosine kinase-like domain. | 5.36e-06 | 2 | 81 | 2 | 1334494 | |
| Pubmed | Neurite extension in central neurons: a novel role for the receptor tyrosine kinases Ror1 and Ror2. | 5.36e-06 | 2 | 81 | 2 | 15654020 | |
| Pubmed | Evolutionary divergence in the catalytic activity of the CAM-1, ROR1 and ROR2 kinase domains. | 5.36e-06 | 2 | 81 | 2 | 25029443 | |
| Pubmed | Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. | 5.36e-06 | 2 | 81 | 2 | 11455430 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26515598 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11713269 | ||
| Pubmed | The Cell Surface Receptors Ror1/2 Control Cardiac Myofibroblast Differentiation. | 5.36e-06 | 2 | 81 | 2 | 34155901 | |
| Pubmed | Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies. | 5.36e-06 | 2 | 81 | 2 | 22988987 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 26862065 | ||
| Pubmed | ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. | 5.36e-06 | 2 | 81 | 2 | 29395309 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 33894267 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 37430307 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 10231392 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24104062 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 38587578 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12898527 | ||
| Pubmed | Ror1-Ror2 complexes modulate synapse formation in hippocampal neurons. | 1.60e-05 | 3 | 81 | 2 | 19958813 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 27384677 | ||
| Pubmed | Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation. | 1.60e-05 | 3 | 81 | 2 | 26690702 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SHROOM3 IGF1R EXPH5 MATK ROR2 ZBTB21 KMT2A MAGI3 DCLK2 SRRM2 | 3.15e-05 | 861 | 81 | 10 | 36931259 |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 12754255 | ||
| Pubmed | Structure and Conformational Dynamics of the Human Spliceosomal Bact Complex. | 3.20e-05 | 4 | 81 | 2 | 29361316 | |
| Pubmed | Essential role of Wnt5a-Ror1/Ror2 signaling in metanephric mesenchyme and ureteric bud formation. | 3.20e-05 | 4 | 81 | 2 | 26840931 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 21799000 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 28885975 | ||
| Pubmed | 3.96e-05 | 268 | 81 | 6 | 33640491 | ||
| Pubmed | Quantitative trait loci affecting peak bone mineral density in mice. | 5.33e-05 | 5 | 81 | 2 | 9797472 | |
| Pubmed | 5.33e-05 | 5 | 81 | 2 | 25043182 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 5.74e-05 | 420 | 81 | 7 | 28065597 | |
| Pubmed | 7.99e-05 | 6 | 81 | 2 | 22328498 | ||
| Pubmed | p300-mediated acetylation stabilizes the Th-inducing POK factor. | 7.99e-05 | 6 | 81 | 2 | 20810990 | |
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 22343533 | ||
| Pubmed | 1.12e-04 | 7 | 81 | 2 | 33480845 | ||
| Pubmed | 1.13e-04 | 40 | 81 | 3 | 30898150 | ||
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 1.49e-04 | 8 | 81 | 2 | 22722839 | |
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 30801848 | ||
| Pubmed | 1.49e-04 | 8 | 81 | 2 | 31306714 | ||
| Pubmed | 1.55e-04 | 493 | 81 | 7 | 15368895 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.68e-04 | 220 | 81 | 5 | 35785414 | |
| Pubmed | Wnt5a regulates growth, patterning, and odontoblast differentiation of developing mouse tooth. | 2.38e-04 | 10 | 81 | 2 | 21246660 | |
| Pubmed | 2.38e-04 | 10 | 81 | 2 | 25082826 | ||
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 8223273 | ||
| Pubmed | Bmp4 from the optic vesicle specifies murine retina formation. | 2.91e-04 | 11 | 81 | 2 | 25792196 | |
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 18948417 | ||
| Pubmed | 2.91e-04 | 11 | 81 | 2 | 21949878 | ||
| Pubmed | 3.48e-04 | 12 | 81 | 2 | 29292497 | ||
| Pubmed | Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells. | 4.11e-04 | 13 | 81 | 2 | 18087045 | |
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 14973275 | ||
| Pubmed | 4.11e-04 | 13 | 81 | 2 | 24270184 | ||
| Pubmed | A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. | 4.79e-04 | 14 | 81 | 2 | 8114702 | |
| Pubmed | Expression of insulin-like growth factor binding proteins during mouse cochlear development. | 4.79e-04 | 14 | 81 | 2 | 23813480 | |
| Pubmed | 6.21e-04 | 814 | 81 | 8 | 23251661 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 23584732 | ||
| Pubmed | 6.29e-04 | 16 | 81 | 2 | 35714603 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DDR1 SHROOM3 IGF1R NRF1 CACNA2D2 ROR2 LRRC27 XPNPEP3 MAGI3 DCLK2 EIF2AK4 | 6.60e-04 | 1489 | 81 | 11 | 28611215 |
| Pubmed | Notum attenuates Wnt/β-catenin signaling to promote tracheal cartilage patterning. | 8.00e-04 | 18 | 81 | 2 | 29428562 | |
| Pubmed | Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded. | 8.00e-04 | 18 | 81 | 2 | 20593419 | |
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 8.00e-04 | 18 | 81 | 2 | 28068325 | |
| Pubmed | Canonical WNT Signaling Regulates the Pituitary Organizer and Pituitary Gland Formation. | 8.93e-04 | 19 | 81 | 2 | 28938441 | |
| Pubmed | 8.93e-04 | 19 | 81 | 2 | 25263594 | ||
| Pubmed | Requirement for Mab21l2 during development of murine retina and ventral body wall. | 8.93e-04 | 19 | 81 | 2 | 15385160 | |
| Pubmed | 9.91e-04 | 20 | 81 | 2 | 22267199 | ||
| Pubmed | 9.91e-04 | 20 | 81 | 2 | 20660756 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 1.06e-03 | 495 | 81 | 6 | 27705803 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.07e-03 | 1105 | 81 | 9 | 35748872 | |
| Pubmed | Pancreatic islet and progenitor cell surface markers with cell sorting potential. | 1.08e-03 | 86 | 81 | 3 | 21947380 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 1.09e-03 | 497 | 81 | 6 | 36774506 | |
| Pubmed | 1.09e-03 | 21 | 81 | 2 | 2307474 | ||
| Pubmed | 1.09e-03 | 21 | 81 | 2 | 12072567 | ||
| Pubmed | 1.14e-03 | 689 | 81 | 7 | 36543142 | ||
| Pubmed | 1.19e-03 | 339 | 81 | 5 | 30415952 | ||
| Pubmed | 1.20e-03 | 22 | 81 | 2 | 8452817 | ||
| Pubmed | MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. | 1.20e-03 | 22 | 81 | 2 | 34032267 | |
| Pubmed | 1.31e-03 | 23 | 81 | 2 | 36800350 | ||
| Pubmed | 1.34e-03 | 709 | 81 | 7 | 22988430 | ||
| Pubmed | Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. | 1.43e-03 | 24 | 81 | 2 | 20705733 | |
| Pubmed | Negative control of Smad activity by ectodermin/Tif1gamma patterns the mammalian embryo. | 1.43e-03 | 24 | 81 | 2 | 20573697 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.55e-03 | 533 | 81 | 6 | 30554943 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.58e-03 | 361 | 81 | 5 | 26167880 | |
| Pubmed | β-catenin is required in the neural crest and mesencephalon for pituitary gland organogenesis. | 1.68e-03 | 26 | 81 | 2 | 27184910 | |
| Pubmed | Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. | 1.68e-03 | 26 | 81 | 2 | 19060910 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.72e-03 | 101 | 81 | 3 | 23382219 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.80e-03 | 372 | 81 | 5 | 22939624 | |
| Pubmed | 1.81e-03 | 27 | 81 | 2 | 26764381 | ||
| Pubmed | 1.81e-03 | 27 | 81 | 2 | 31257105 | ||
| Pubmed | 1.82e-03 | 103 | 81 | 3 | 10574462 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 1.86e-03 | 375 | 81 | 5 | 32788342 | |
| Pubmed | PCF11 ZBTB21 KMT2A MAGI3 FAM47B EIF2AK4 ACTN3 PLA2G4D PRPF8 RPL3 | 1.88e-03 | 1442 | 81 | 10 | 35575683 | |
| Pubmed | 1.95e-03 | 28 | 81 | 2 | 18593464 | ||
| Pubmed | 2.04e-03 | 383 | 81 | 5 | 19453261 | ||
| Pubmed | 2.06e-03 | 1215 | 81 | 9 | 15146197 | ||
| Pubmed | Direct and indirect requirements of Shh/Gli signaling in early pituitary development. | 2.09e-03 | 29 | 81 | 2 | 20934421 | |
| Pubmed | 2.09e-03 | 29 | 81 | 2 | 17577209 | ||
| Pubmed | 2.09e-03 | 29 | 81 | 2 | 19279220 | ||
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 2.09e-03 | 29 | 81 | 2 | 22956684 | |
| Pubmed | 2.09e-03 | 29 | 81 | 2 | 17359964 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 5.47e-04 | 211 | 81 | 4 | chr1p13 | |
| Cytoband | 16p13.3 | 9.40e-04 | 244 | 81 | 4 | 16p13.3 | |
| Cytoband | 4q31.3 | 1.38e-03 | 31 | 81 | 2 | 4q31.3 | |
| Cytoband | 1p13.1 | 1.57e-03 | 33 | 81 | 2 | 1p13.1 | |
| Cytoband | Xp21.1 | 1.66e-03 | 34 | 81 | 2 | Xp21.1 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.05e-06 | 40 | 49 | 4 | 321 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | BMP4 SHROOM3 CCPG1 CEP78 NRF1 CACNA2D2 IQCC GNPTAB LRRC27 FHDC1 ACTN3 TNNI1 SRRM2 PSRC1 ZNF710 WDR24 USP21 THAP7 | 9.54e-07 | 1371 | 75 | 18 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 188 | 81 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 188 | 81 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-06 | 188 | 81 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.23e-06 | 188 | 81 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.39e-06 | 192 | 81 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.52e-06 | 195 | 81 | 6 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.61e-06 | 197 | 81 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 199 | 81 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.07e-05 | 159 | 81 | 5 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-05 | 173 | 81 | 5 | b799c06a6a5754668e789f70c0c8bc1508568575 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-05 | 176 | 81 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 177 | 81 | 5 | 9b4c1ca5c6fca9a7a936dad49a04155903ef9c32 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Tuft|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 178 | 81 | 5 | f17c3b7bb562ac24c6a03fe3c9ba94c2b434c141 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-05 | 178 | 81 | 5 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 178 | 81 | 5 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.89e-05 | 179 | 81 | 5 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 180 | 81 | 5 | cfc8bfbfd3617aabbb49f9730c29b673ca157e74 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 180 | 81 | 5 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 183 | 81 | 5 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-05 | 184 | 81 | 5 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 185 | 81 | 5 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 187 | 81 | 5 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.52e-05 | 190 | 81 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.58e-05 | 191 | 81 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.65e-05 | 192 | 81 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.78e-05 | 194 | 81 | 5 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.85e-05 | 195 | 81 | 5 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.07e-05 | 198 | 81 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.14e-05 | 199 | 81 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.22e-05 | 200 | 81 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.78e-05 | 128 | 81 | 4 | 7e3f5cea91af005f08d8e9340fb8630bf1c887c3 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.78e-05 | 128 | 81 | 4 | a876303c852db2af9418d1a1711d7c950805018a | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Excitatory_Neuron.Slc17a6.Oprk1_(Claustrum_cortex)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.78e-05 | 128 | 81 | 4 | 388062f840fd04cb8087f27a9a78e7a192920e3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.05e-05 | 129 | 81 | 4 | 2f30b4897343586c9b49a1d2bec3007ec737085c | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.24e-04 | 140 | 81 | 4 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-2|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.31e-04 | 142 | 81 | 4 | 112f1b1bf7622e3bc1a2094c7710fab5a4083481 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-04 | 146 | 81 | 4 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.97e-04 | 158 | 81 | 4 | 9dea15b28f64206bac0e785df6f36a2cc9010ac7 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 2.02e-04 | 159 | 81 | 4 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.02e-04 | 159 | 81 | 4 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 161 | 81 | 4 | bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 165 | 81 | 4 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-04 | 166 | 81 | 4 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 167 | 81 | 4 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.44e-04 | 167 | 81 | 4 | 9b9b4cad0b35d121256176600ea4705759c105d3 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-04 | 168 | 81 | 4 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.49e-04 | 168 | 81 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 168 | 81 | 4 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 168 | 81 | 4 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-04 | 169 | 81 | 4 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-04 | 169 | 81 | 4 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 2.61e-04 | 170 | 81 | 4 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 170 | 81 | 4 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-04 | 172 | 81 | 4 | 86f52f486d67217fc1b8443ab362c975df2974a4 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-04 | 172 | 81 | 4 | b043d4f81dced7fb3326043f68474123be47cc5d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-04 | 172 | 81 | 4 | fb2df8fea6df5947165f13978f1d1006d15b60fd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-04 | 172 | 81 | 4 | e38ebb216e4ddcd008148fcbaf709b4f3c83706a | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 173 | 81 | 4 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.85e-04 | 174 | 81 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-04 | 175 | 81 | 4 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.91e-04 | 175 | 81 | 4 | 955f10982a487e12cdc3a9f80b3be06bf6c59de7 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.98e-04 | 176 | 81 | 4 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-04 | 177 | 81 | 4 | b75f519d72611b293d9684f7dcfb1b70fbf54a90 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-04 | 177 | 81 | 4 | c1f838e425ebb04482829b1957e3c1347127e6de | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-04 | 179 | 81 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-04 | 179 | 81 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.17e-04 | 179 | 81 | 4 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.24e-04 | 180 | 81 | 4 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.24e-04 | 180 | 81 | 4 | d33bb00f2b7d07dda9015cb8eafd742c2b2e9ace | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 181 | 81 | 4 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.31e-04 | 181 | 81 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 181 | 81 | 4 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | AT1-AT2_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 3.31e-04 | 181 | 81 | 4 | ca23ce4f2c7b684d8ddd0e8619b3b696023d75e3 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.38e-04 | 182 | 81 | 4 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 3.38e-04 | 182 | 81 | 4 | 6e35892fa959ee31591850ded8f1088195ddeb01 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 183 | 81 | 4 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 3.45e-04 | 183 | 81 | 4 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 183 | 81 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 3.45e-04 | 183 | 81 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.52e-04 | 184 | 81 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.52e-04 | 184 | 81 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 184 | 81 | 4 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 184 | 81 | 4 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.52e-04 | 184 | 81 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-04 | 185 | 81 | 4 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 3.60e-04 | 185 | 81 | 4 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.60e-04 | 185 | 81 | 4 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.60e-04 | 185 | 81 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.60e-04 | 185 | 81 | 4 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.60e-04 | 185 | 81 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-04 | 186 | 81 | 4 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 3.67e-04 | 186 | 81 | 4 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 186 | 81 | 4 | ca5e9c6531cb5d199e27509bfab1d62e3937177e | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.67e-04 | 186 | 81 | 4 | 1ed71b229f40a680071b14f5a7a19706e0fd14b1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-04 | 186 | 81 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 3.67e-04 | 186 | 81 | 4 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-04 | 186 | 81 | 4 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| Drug | Artemisinin [63968-64-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.21e-06 | 199 | 75 | 7 | 7247_DN | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 1.77e-04 | 8 | 75 | 2 | EFO_0801777 | |
| Disease | myelofibrosis (is_implicated_in) | 1.77e-04 | 8 | 75 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 6.55e-04 | 15 | 75 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Lewy Body Disease | 1.42e-03 | 22 | 75 | 2 | C0752347 | |
| Disease | physical activity | 1.48e-03 | 88 | 75 | 3 | EFO_0003940 | |
| Disease | Adenocarcinoma of large intestine | 1.90e-03 | 96 | 75 | 3 | C1319315 | |
| Disease | longevity, healthspan, parental longevity | 2.48e-03 | 29 | 75 | 2 | EFO_0004300, EFO_0007796, EFO_0009762 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IQRRSARPPRAKEKH | 156 | Q96MC4 | |
| ARPPRAKEKHRAALS | 161 | Q96MC4 | |
| KRRRSLPRPHDFFDA | 386 | Q6ZN18 | |
| RAPKKIDLYDVRRRP | 266 | Q9NY47 | |
| RVFRPRKLDRFHPKE | 1141 | Q9P2K8 | |
| PRVDFPRSRLRFKEK | 601 | Q08345 | |
| RHVKGRVDPHFRAPK | 16 | A6NKQ9 | |
| ERAKRHRGFPLIKTR | 396 | Q5JTW2 | |
| HLARKRRRPVSPERY | 101 | Q8WXF8 | |
| GHALTRRRRAKRSPK | 281 | P12644 | |
| GHFKKRSRPDLRTRA | 406 | Q8IXJ9 | |
| HKLRIKSRASGRVPR | 266 | A0A5F9ZHS7 | |
| RGLKPRNHCPRKSRT | 326 | Q4KMZ1 | |
| RSKKLPRVREHRGPL | 91 | Q86XR2 | |
| NRPPRSSKAHRKRER | 86 | Q7L8S5 | |
| AKRKHRRLRFPPVDT | 31 | Q5HY64 | |
| LRRASSARAPKKRPE | 1086 | Q9C0D6 | |
| KPPSRRQRHRFPTKE | 191 | Q6Y2X3 | |
| TGKRPSARFPHQRRK | 61 | Q96GY3 | |
| ARRPPFRKLAEKLAR | 466 | P42679 | |
| IRHFREPIRLKTVKP | 91 | Q5TCQ9 | |
| TVDPRLFKKRRLRSP | 71 | P01138 | |
| PRRRIHKEASPNRIR | 1241 | Q3T906 | |
| PLQKKRRRGLFHFRR | 1046 | Q8ND23 | |
| HFEERDKRPRPGSRR | 11 | Q8N568 | |
| GSRRPHRKPTILRKI | 1156 | Q8N6G6 | |
| VSKFRHTEARPPRRE | 6 | P57737 | |
| LHNSIFVPRPERKRR | 726 | P08069 | |
| LRPRRYRAPSHDKVA | 261 | Q8NHB1 | |
| AKRKHRRLRFPPVDT | 31 | Q8NA70 | |
| RKRPHVFESNPSIRK | 91 | Q16656 | |
| KDFIRVHRLPRPLKQ | 496 | Q9UQ05 | |
| ASRKFPAKDVSPRRH | 1601 | Q8NEV8 | |
| LLRKSHPPKVRERHF | 1806 | Q8NEV8 | |
| PKKKCFVFDRPVHRR | 231 | P32455 | |
| RLTAPFRKHVRPKKQ | 121 | Q96FB5 | |
| RRVKPSPRRETFVLK | 106 | Q6PGN9 | |
| RRHKKRTFLRPRIIG | 396 | Q04756 | |
| KSRSPIIHSPKRRDR | 486 | O94913 | |
| IIHSPKRRDRRSPKR | 491 | O94913 | |
| PSPAFRRRRARKKTV | 171 | Q9ULG6 | |
| SREKPRFHKPCRNDL | 26 | Q6ZN03 | |
| RKRALFPEPRKHALF | 546 | Q96JM3 | |
| SQPKPKHDGRRRIRE | 156 | P36383 | |
| GAQKRRHKPRRADSP | 136 | K9M1U5 | |
| RHKPRRADSPRCRKA | 141 | K9M1U5 | |
| RKRKVFSPIRSEPRS | 736 | Q03164 | |
| KLHSRRRREAPKTSP | 101 | Q5TAT6 | |
| HPPDACAFRRGRKKR | 206 | Q92826 | |
| KRVRDLRHPKRILFG | 346 | H0Y7S4 | |
| PQHDSPAKKCRLRRR | 211 | Q8TE04 | |
| RTALKHRTLEARPPR | 801 | Q86XP0 | |
| QPRRKRLKSDERPVH | 1111 | Q9UPN9 | |
| KRPNPDILDHERKRR | 51 | Q9UQ35 | |
| LPKPRHVFRRKTASS | 301 | Q9C0I9 | |
| FLPRKRSSRHRGKVK | 16 | P39023 | |
| SHSPVKRPRKAQRLR | 51 | P78549 | |
| LRRRKRFKRAELPAH | 161 | Q13461 | |
| HGPFFPRILRRRKGK | 361 | Q9BZQ2 | |
| KLRLKHRRSEPAGRP | 146 | Q8TF72 | |
| EFPSRRPRFKDIHSR | 731 | Q01974 | |
| RPIRPHRNISALKRD | 266 | Q66K14 | |
| RGISFHRLPKKDNPR | 21 | Q9BT49 | |
| RDYRRLHKPPRIQEK | 331 | Q08043 | |
| SREDGRPRKERRPHK | 611 | Q02040 | |
| EIPSRRPRFKDIHVR | 731 | Q01973 | |
| RDRRHFKRMRFPPFD | 156 | Q6P2Q9 | |
| PAKRRFQADRRLPFK | 481 | Q9ULJ3 | |
| KLPFAPRARSKERRN | 26 | Q9UK80 | |
| PVARRSRKPRKAFLQ | 196 | O15156 | |
| RSFKRRPKLPDNEVH | 721 | Q7Z392 | |
| KRRFITVSKRAPRPR | 776 | P38935 | |
| RKKAPHRLCGRFSRI | 486 | Q96GP6 | |
| HPRAGAELRRFRKRP | 1136 | O15067 | |
| RPREHSLKKRGTRSL | 116 | O94964 | |
| PRARKNRSHIPLVRK | 256 | Q8NFV5 | |
| CEKHTRRKTRPPVRL | 91 | Q8N1W2 | |
| GKFKRPPLRRVRVSA | 106 | P19237 | |
| ARRWRKKRRAHPPED | 76 | Q92785 | |
| KKRRAHPPEDPRLSF | 81 | Q92785 | |
| PPRKRRSRTEFALKE | 26 | Q8N9R8 | |
| SHKAILFVPRRDPSR | 146 | Q9NQH7 | |
| GDRRHPIFFKRKLDP | 371 | Q96S15 | |
| PSKQVKPLFRHFRRI | 286 | Q9UHV5 | |
| RAASRPRKAEPHSFR | 21 | Q63HR2 | |
| PRKAEPHSFREKVFR | 26 | Q63HR2 | |
| TPHGRFRDLRKSKFR | 391 | Q562E7 | |
| KRRRKRGRFHPGFET | 811 | Q7Z570 |